Press Releases

12345678910
Wedgewood Weddings Expands to Maryland With Grey Rock Mansion
Historic Pikesville estate brings timeless architecture, garden ceremonies, and a renewed vision for indoor-outdoor celebrations to the Baltimore wedding market
By Wedgewood Weddings · Via ACCESS Newswire · November 4, 2026
Jumia to Announce Third Quarter 2026 Results on November 18, 2026
LAGOS, NIGERIA / ACCESS Newswire / November 4, 2026 / Jumia Technologies AG (NYSE:JMIA) ("Jumia") today announced that it will release results for the third quarter 2026 before the U.S. market opens on Wednesday, November 18, 2026.
By Jumia Technologies AG · Via ACCESS Newswire · November 4, 2026
Ringler Hires New Settlement Consultant in California
NEWPORT BEACH, CA / ACCESS Newswire / November 4, 2026 / Ringler, the nation's largest structured settlement planning company, is pleased to announce that Ramtin Gahneeian has joined the firm as a Settlement Consultant, bringing extensive industry expertise, leadership, and a deep commitment to education and advocacy within the structured settlement community.
By Ringler · Via ACCESS Newswire · November 4, 2026
BFCH Plans 10-Fold Increase in Regulation A Offering Price to $0.001 Per Share
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · November 4, 2026
Libra Energy Materials to Present at Kamoa Capital Investor Webinar on November 11
Toronto, Ontario--(Newsfile Corp. - November 4, 2026) - Libra Energy Materials Inc. (CSE: LIBR) (OTCQB: LIBRF) (FSE: W0R0) ("Libra" or the "Company") is pleased to announce that it will present at an investor webinar hosted by Kamoa Capital on Wednesday, November 11, 2026.
Via Newsfile · November 4, 2026
Arc Mineral Royalties Announces Board Changes
Appointment strengthens Board as Arc continues to build its mining royalty portfolio
Via Newsfile · November 4, 2026
WildBrain Announces Preliminary Results of Its Substantial Issuer Bid
Toronto, Ontario--(Newsfile Corp. - November 4, 2026) - WildBrain Ltd. (TSX: WILD) ("WildBrain" or the "Company"), a global leader in family entertainment, announced today the preliminary results of its substantial issuer bid (the "Offer") to purchase for cancellation up to C$20,000,000 of its outstanding common shares (the "Common Shares") pursuant to a modified Dutch auction at a purchase price (the "Purchase Price") between C$1.30 and C$1.45 per Common Share. The Offer expired at 5:00 p.m. (Eastern time) on November 3, 2026. Shareholders could tender Common Shares by way of auction tenders at prices within the range or by way of purchase price tenders. All Common Shares purchased under the Offer will be purchased at the same Purchase Price, and Common Shares tendered at prices above the Purchase Price will be returned to shareholders.
Via Newsfile · November 4, 2026
Angkor Resources' Enercam Submits Drilling Contractor Tender To The Ministry Of Mines And Energy
GRANDE PRAIRIE, ALBERTA (November 4, 2026) – TheNewswire - ANGKOR RESOURCES CORP. (TSXV: ANK OTCQB: ANKOF) (“ANGKOR” OR “THE COMPANY”) announces that its Cambodian energy subsidiary, EnerCam Resources Co., Ltd. (“EnerCam”), has sent the terms of its comprehensive drilling contractor tender to Cambodia’s Ministry of Mines and Energy (“MME”) for review. Once reviewed and approved by MME, the tender will be public so that drilling companies can bid to drill the exploratory wells on Block VIII.
Via TheNewswire.com · November 4, 2026
Frontier Medicines to Present Preclinical Data for FMC-242, a Novel Covalent Allosteric PI3Kα-RAS Breaker, at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Frontier Medicines Corporation (Frontier), a clinical-stage, AI-powered precision medicines company that discovers and develops covalent medicines for previously undruggable and hard-to-drug disease-causing targets, starting with cancer, today announced that it will present preclinical data from its FMC-242 program at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, taking place in Barcelona, Spain, from November 18–20. FMC-242 is a novel, orally bioavailable, covalent allosteric breaker of the PI3Kα-RAS interaction designed using Frontier’s proprietary, AI-powered CovalentAI™ Platform. PI3Kα is the second most frequently mutated oncogene in human cancer and plays an essential role in both PI3Kα and RAS-driven cancers.
By Frontier Medicines Corporation · Via Business Wire · November 4, 2026
Marriott Vacations Worldwide Reports Third Quarter 2026 Financial Results
Marriott Vacations Worldwide Corporation (NYSE: VAC) (“MVW,” the “Company,” “we” or “our”) reported financial results for the third quarter of 2026.
Empower Brands Announces Proposal to Acquire Helen of Troy Ltd. for $37.00 Per Share in Cash
Empower Brands Holdings Group, LLC (“Empower Brands”), the Home & Personal Care business jointly owned by Spectrum Brands Holdings, Inc. (“Spectrum Brands” or “SPB”) (NYSE: SPB) and funds managed by Oaktree Capital Management, L.P. (“Oaktree”), announced it has submitted a non-binding proposal (the “Proposal”) to the Board of Directors of Helen of Troy Limited (“Helen of Troy”, “HELE” or the “Company”) (NASDAQ: HELE) to acquire 100% of the outstanding common equity of Helen of Troy in an all-cash transaction (the “Transaction”) for $37.00 per share at an implied enterprise value of approximately $1.6 billion. An affiliate of Empower Brands currently owns approximately 4.5% of the Company’s outstanding shares, reflecting its conviction in the value and strategic merits of the proposed Transaction.
By Spectrum Brands Holdings, Inc. · Via Business Wire · November 4, 2026
Assured Guaranty Ltd. Declares Quarterly Dividend of $0.38 per Common Share
Assured Guaranty Ltd. (NYSE:AGO) today declared a quarterly dividend of $0.38 per common share. The dividend is payable on December 2, 2026 to shareholders of record at the close of business on November 18, 2026.
By Assured Guaranty Ltd. · Via Business Wire · November 4, 2026
Prolink Partners with Nurses on Boards Coalition to Promote More Nurses into Healthcare Leadership Roles
Prolink, a premier workforce solutions firm, has been selected as a new member organization of the Nurses on Boards Coalition (NOBC), a national coalition that works to improve the health of communities by increasing nurses’ influence on boards and other leadership roles. NOBC set a goal of having 30,000 board seats filled by nurses by 2035. The coalition serves more than 30,000 nurses, along with strategic partners, sponsors, and member organizations with education, placement assistance, mentoring, and developing evidence of the impact of nurses serving on boards.
By Prolink · Via Business Wire · November 4, 2026
AN2 Therapeutics Advances Pipeline With Development Candidate Nomination for Hypophosphatasia (HPP)
AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical-stage biopharmaceutical company discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced the advancement of AN2-504661, a novel boron-based ENPP1 inhibitor, as a development candidate for the treatment of HPP.
By AN2 Therapeutics, Inc. · Via Business Wire · November 4, 2026
Bruker Reports Third Quarter 2026 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and nine months ended September 30, 2026.
By Bruker Corporation · Via Business Wire · November 4, 2026
Reynolds Consumer Products Reports Third Quarter 2026 Financial Results
Reynolds Consumer Products Inc. (the “Company”) (Nasdaq: REYN) today reported financial results for the third quarter ended September 30, 2026.
By Reynolds Consumer Products Inc. · Via Business Wire · November 4, 2026
Sapphiros and binx health Combine to Form Onvaro, a Next-Generation Diagnostics Company
Sapphiros, a diagnostics platform backed by investment funds managed by KKR, and binx health, a point-of-care diagnostics company backed by Hildred, a health care-focused private equity firm, today announced that they have combined to form Onvaro, a next-generation diagnostics company built to bring fast, accurate, and affordable testing to the point of need across health care and consumer settings. As part of this combination, investment funds managed by KKR, through its Health Care Strategic Growth strategy, Hildred, and EQT Life Sciences are investing capital to support Onvaro’s growth trajectory.
By KKR & Co. Inc. · Via Business Wire · November 4, 2026
Palmer Square Capital BDC Inc. Announces Third Quarter 2026 Financial Results
Palmer Square Capital BDC Inc. (NYSE: PSBD) (“PSBD” or the “Company”), an externally managed business development company, today announced its financial results for the third quarter ended September 30, 2026.
By Palmer Square Capital BDC Inc. · Via Business Wire · November 4, 2026
SelectQuote, Inc. Reports First Quarter of Fiscal Year 2027 Results
SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the first quarter of fiscal year 2027 of $280.0 million compared to consolidated revenue for the first quarter of fiscal year 2026 of $328.8 million. Consolidated net loss for the first quarter of fiscal year 2027 was $20.3 million compared to consolidated net loss for the first quarter of fiscal year 2026 of $30.5 million. Consolidated Adjusted EBITDA* for the first quarter of fiscal year 2027 was $(17.0) million compared to consolidated Adjusted EBITDA* for the first quarter of fiscal year 2026 of $(32.1) million. Consolidated cash used in operations during the first quarter of fiscal year 2027 was $17.2 million compared to $21.6 million used during the first quarter of fiscal year 2026.
By SelectQuote, Inc. · Via Business Wire · November 4, 2026
Senior Living Clinical Leaders Carry the Accountability, But Not Always the Authority, New August Health and ASHA Survey Finds
August Health and the American Seniors Housing Association (ASHA) today released the 2026 State of Senior Living Clinical Leadership Survey, revealing that only 21% of clinical leaders say their influence and authority fully match the responsibilities they are held accountable for. The findings highlight opportunities for senior living operators to better support the people leading resident care through greater decision-making authority, staff development, and access to reliable data.
By August Health · Via Business Wire · November 4, 2026
Insulet Reports Third Quarter 2026 Results
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the three months ended September 30, 2026.
By Insulet Corporation · Via Business Wire · November 4, 2026
CPI Reports Record Third Quarter 2026 Results
CPI Card Group Inc. (Nasdaq: PMTS) (“CPI” or the “Company”), a payments technology leader providing a comprehensive range of physical and digital payment solutions for U.S. financial institutions, processors, fintechs, prepaid program managers and more, today reported financial results for the quarter ended September 30, 2026 and increased its 2026 financial guidance targets for revenue growth and Free Cash Flow, while affirming all other guidance targets.
By CPI Card Group · Via Business Wire · November 4, 2026
Signatera™ in Head and Neck Cancer: Three New Publications Demonstrate Strong Clinical Performance and Actionability
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced three peer-reviewed publications in npj Precision Oncology, JAMA Otolaryngology, and Advances in Radiation Oncology, highlighting the performance of its Signatera test in head and neck squamous cell carcinoma (HNSCC).
By Natera, Inc. · Via Business Wire · November 4, 2026
SharkNinja Reports Third Quarter 2026 Results
SharkNinja, Inc. (“SharkNinja” or the “Company”) (NYSE: SN), a global product design and technology company, today announced its financial results for the third quarter ended September 30, 2026.
By SharkNinja · Via Business Wire · November 4, 2026
CDW Reports Third Quarter 2026 Earnings
CDW Corporation (Nasdaq: CDW):
By CDW Corporation · Via Business Wire · November 4, 2026
United Therapeutics Announces Buydown of Ralinepag Royalty
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that it has entered into an amendment with Arena Pharmaceuticals, Inc. (Arena), a subsidiary of Pfizer Inc., which eliminates all royalty obligations under its exclusive license agreement related to ralinepag in exchange for an up-front payment of $525 million.
By United Therapeutics Corporation · Via Business Wire · November 4, 2026
Dine Brands Global, Inc. Reports Third Quarter 2026 Results
Dine Brands Global, Inc. (NYSE: DIN) (the “Company” or “Dine Brands”), the parent company of Applebee’s Neighborhood Grill + Bar®, IHOP® and Fuzzy’s Taco Shop® restaurants, today announced financial results for the third quarter of fiscal year 2026.
By Dine Brands Global, Inc. · Via Business Wire · November 4, 2026
Cushman & Wakefield Reports Financial Results for the Third Quarter 2026
Cushman & Wakefield Ltd. (NYSE: CWK) today reported financial results for the third quarter of 2026. Diluted earnings per share (“EPS”) was $0.22, flat with prior year, while Adjusted EPS was $0.37, up 28%.
By Cushman & Wakefield · Via Business Wire · November 4, 2026
Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immunological diseases, today announced that members of management will participate in the following investor conferences.
By Enanta Pharmaceuticals, Inc. · Via Business Wire · November 4, 2026
Olympus Cosmetic Group to Deploy AI Med Consult Across Its Practices
Olympus Cosmetic Group, a surgeon-led partnership platform purpose-built for leading aesthetic surgery practices, has signed an agreement with AI Med Consult to introduce its AI-powered patient engagement technology across its growing network of 18 locations. The partnership supports Olympus' commitment to equipping surgeon partners with innovative resources that enhance patient experience, strengthen practice operations, and support long-term growth.
By AI Med Consult · Via Business Wire · November 4, 2026
Definium Therapeutics Presents Topline Phase 3 Data for DT120 ODT in Generalized Anxiety Disorder and Major Depressive Disorder at 2026 NEI Fall Congress
Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced four poster presentations at the 2026 NEI Fall Congress taking place November 5 through 8 in Colorado Springs, CO.
By Definium Therapeutics, Inc. · Via Business Wire · November 4, 2026
Kraft Heinz Reports Third Quarter 2026 Results; Updates 2026 Full Year Outlook
The Kraft Heinz Company (NYSE: KHC) (“Kraft Heinz” or the “Company”) today reported financial results for the third quarter of 2026.
By The Kraft Heinz Company · Via Business Wire · November 4, 2026
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2026
BANNOCKBURN, Ill., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2026.
By Option Care Health, Inc. · Via GlobeNewswire · November 4, 2026
Charles River Laboratories Announces Third-Quarter 2026 Results
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter ended September 26, 2026.
908 Devices to Participate in the Stifel 2026 Healthcare Conference
908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced that management will participate in a fireside chat at the Stifel 2026 Healthcare Conference on Wednesday, November 11, 2026 at 4:00 p.m. ET.
By 908 Devices · Via Business Wire · November 4, 2026
Smith Douglas Homes Reports Third Quarter 2026 Results
Smith Douglas Homes Corp. (NYSE: SDHC) (“Smith Douglas” or the “Company”) today announced third quarter results for the three and nine months ended September 30, 2026.
By Smith Douglas Homes Corp. · Via Business Wire · November 4, 2026
Odyssey Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Additional analyses from the Phase 2a induction period for OD-001 further strengthen clinical proof of concept in ulcerative colitis
By Odyssey Therapeutics Inc · Via GlobeNewswire · November 4, 2026
Flutter Entertainment PLC: Q3 2026 Earnings Release
By Flutter Entertainment PLC · Via GlobeNewswire · November 4, 2026
Royalty Pharma reports third quarter 2026 results
NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the third quarter of 2026 and raised full year 2026 guidance for Portfolio Receipts.
By Royalty Pharma plc · Via GlobeNewswire · November 4, 2026
D-Wave Boosts Stride Hybrid Solver Performance, Launches Developer Training to Accelerate Quantum Optimization Adoption
D-Wave Quantum Inc. (NASDAQ: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced powerful performance enhancements to its Stride™ hybrid solver. In key benchmark testing, the enhanced solver found better solutions in 15 seconds than the previous version found in 120 seconds. In addition, the Company also launched a new, three-course Applied Quantum Optimization learning path to accelerate hybrid-quantum optimization adoption. Together, the enhanced solver and training courses further equip developers to apply quantum optimization to complex, real-world business challenges.
By D-Wave Quantum Inc. · Via Business Wire · November 4, 2026
Ocugen Provides Business Update with Third Quarter 2026 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET
By Ocugen · Via GlobeNewswire · November 4, 2026
Performance Food Group Company Reports First-Quarter Fiscal 2027 Results
Performance Food Group Company (“PFG” or the “Company”) (NYSE: PFGC) today announced its first-quarter fiscal 2027 business results.
By Performance Food Group Company · Via Business Wire · November 4, 2026
Rapport Therapeutics Reports Third Quarter 2026 Financials and Provides Business Update
Positive topline results from Phase 2 trial of RAP-219 in bipolar mania; initiation of two Phase 3 trials in bipolar mania expected in 2H 2027
By Rapport Therapeutics, Inc. · Via GlobeNewswire · November 4, 2026
BlossomHill Therapeutics Announces Upcoming Presentation for BH-30236, an Oral Macrocyclic CLK Inhibitor, at the 68th American Society of Hematology (ASH) Annual Meeting
Clinical data demonstrate target engagement and support the potential for BH-30236 to address therapeutic resistance in relapsed/refractory AML and HR-MDS
By BlossomHill Therapeutics, Inc. · Via GlobeNewswire · November 4, 2026
X-energy, Alleima, Doosan Enerbility Execute First Order for Nuclear-Industrial Steam Generator Components
ROCKVILLE, Md., Nov. 04, 2026 (GLOBE NEWSWIRE) -- X-Energy, Inc. (Nasdaq: XE) (“X-energy” or the “Company”), a leading developer of advanced nuclear reactors and fuel technology, Alleima, a global manufacturer of advanced stainless steels and special alloys and solutions for industrial heating, and Doosan Enerbility Co., Ltd. (“Doosan”) announced the first procurement of steam generator tubing for the Company’s Xe-100 advanced small modular reactor (“SMR”). The order advances procurement of a safety-significant, long-lead component for the first deployment of the Xe-100, a proposed four-unit plant in partnership with Dow in Texas under the U.S. Department of Energy's Advanced Reactor Demonstration Program (“ARDP”).
By X-Energy, Inc. · Via GlobeNewswire · November 4, 2026
Swisslog Healthcare Powers Hospital Israelita Albert Einstein’s Pharmacy Automation
Swisslog Healthcare, a global industry leader of pharmacy and transport automation solutions, introduced new pharmacy automation innovations to the Brazilian market at the VIII Simpósio Internacional Einstein de Farmácia Hospitalar, Clínica, Radiofarmácia, Pesquisa Clínica, Automação e Oncologia, held Oct. 29 and 30, 2026, at the Centro de Ensino e Pesquisa Einstein in São Paulo, Brazil. The debut reflects a 12-year partnership with Hospital Israelita Albert Einstein, widely recognized as Latin America's leading hospital for healthcare innovation and patient care, and marks a new chapter in Swisslog Healthcare's expanding presence across the region.
By Swisslog Healthcare · Via Business Wire · November 4, 2026
Colliers Reports Third Quarter Results
Solid revenue growth across all three segments
By Colliers International Group Inc · Via GlobeNewswire · November 4, 2026
Agora, Inc. to Report Third Quarter 2026 Financial Results on November 16, 2026
SANTA CLARA, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Agora, Inc. (NASDAQ: API), a pioneer and leader in conversational AI and real-time engagement technology, will report its third quarter 2026 financial results after the close of U.S. markets on November 16, 2026. Agora, Inc. will host a conference call to discuss the financial results at 5 p.m. Pacific Time / 8 p.m. Eastern Time on the same day. Details for the conference call are as follows:
By Agora, Inc. · Via GlobeNewswire · November 4, 2026
Advantage Solutions Reports Third Quarter 2026 Results
Strong top and bottom-line results in Experiential and Retailer Services 
AC Immune Third Quarter 2026 Financial and Corporate Update
AC Immune Third Quarter 2026 Financial and Corporate Update
By AC Immune SA · Via GlobeNewswire · November 4, 2026